COMMUNIQUÉS West-GlobeNewswire

-
Kriya Announces Six Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
22/04/2024 -
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
22/04/2024 -
Cellectis présente de nouveaux procédés d’éditions par TALEN® permettant une insertion et une correction du génome très efficaces dans les cellules souches progénitrices et hématopoïétiques (CSPHs)
22/04/2024 -
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
22/04/2024 -
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
22/04/2024 -
Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting
22/04/2024 -
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
22/04/2024 -
GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
22/04/2024 -
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
22/04/2024 -
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
22/04/2024 -
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
22/04/2024 -
Streamline Health® To Report Fourth Quarter and Fiscal Year 2023 Financial Performance
22/04/2024 -
Abeona Therapeutics Provides Regulatory Update on Pz-cel
22/04/2024 -
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
22/04/2024 -
ArriVent Appoints Kristine Peterson to its Board of Directors
22/04/2024 -
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
22/04/2024 -
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
22/04/2024 -
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
22/04/2024 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
22/04/2024
Pages